Matches 1 - 18 out of 18


Match Document Document Title
US20110070272 Materials and Methods for Modulating Metabolism  
The subject invention provides materials and methods for modulating a variety of biological factors to treat biological conditions associated with the factors. In one embodiment of the invention,...
US20110038944 COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF HEPATOBILIARY DISEASE AND ASSOCIATED DISORDERS  
Provided are nucleic acids comprising ABCB4 gene mutations (e.g., insertions, deletions, frame shift, missense) (e.g., canine ABCB4 1583_1584G) that result in prematurely terminated and/or...
US20140093582 FORMULATION FOR TREATMENT OF DRY MOUTH AND MOUTH SORES  
Serum compositions for application to endothelial tissue are described which contain an amniotic fluid extract in combination with embryonic stem cells. Formulations containing the serum...
US20130209524 METHOD OF USING AMNION ALLOGRAFT IN HEART TRANSPLANT SURGERY  
Improved methods for heart transplant are described. The methods utilize an allograft comprising a layer of amnion to improve the performance and reduce complications of the heart transplant...
US20120201787 TREATMENT OF SPINAL CORD INJURY AND TRAUMATIC BRAIN INJURY USING AMNION DERIVED ADHERENT CELLS  
Provided herein are methods of treating spinal cord and traumatic brain injuries using cells from amnion, and populations of such cells, referred to herein as “amnion derived adherent cells”...
US20130171151 Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease  
Aspects of the invention provide methods for treatment of nonalcoholic steatohepatitis and associated liver fibrosis. In particular, aspects of the invention relate to the use of a therapeutic...
US20130052272 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER  
The present invention concerns pharmaceutical compositions and methods for treating proliferative diseases, e.g. cancer using intracellular and extracellular extracts. These cell extracts can...
US20120020895 BEAR BILE MACROMOLECULAR EXTRACT AND PREPARATION METHOD AND USE THEREOF  
A bear bile macromolecular extract with anti-HCV virus function is disclosed. A preparation method comprises the following steps of: taking fresh bear bile or dissolving bear bile powder with...
US20080286378 Use of Amniotic Fluid (Af) in Treating Ocular Disease and Injury  
Compositions and methods for the treatment of ocular disease and injury are provided. The methods involve the administration of amniotic fluid directly to the eye, for example, as eye drops. The...
US20100003339 FERTILITY AGENT  
Means for improving the success rate of pregnancy on the basis of blastocyst transfer is disclosed. The means comprises an agent for promoting pregnancy in blastocyst transfer comprising the...
US20140079797 SKIN FORMULATION, PREPARATION AND USES THEREOF  
Serum compositions for application to skin are described which contain an amniotic fluid extract in combination with embryonic stem cells. Formulations containing the serum composition are also...
US20130045278 SKIN FORMULATION, PREPARATION AND USES THEREOF  
Serum compositions for application to skin are described which contain an amniotic fluid extract in combination with embryonic stem cells. Formulations containing the serum composition are also...
US20070264352 Biostimulate and tonic solution for massage (solution "Biplatvirs")  
The composition “BIPLATVIRS” is a dark brown liquid, intended for external use by sanative massage. The composition possesses tonic and biostimulant characteristics. The composition can be a...
US20110111047 COMBINATION PREPARATION OF A BIOLOGICAL RESPONSE MODIFIER AND AN ANTICANCER AGENT AND USES THEREOF  
The present invention provides anticancer biological response modifier combinations. In accordance with an aspect of the present invention, there is provided a combination comprising: (i) a...
US20150140114 SKIN TREATMENT PROTOCOL UTILIZING AMNIOTIC SOLUTION  
A skin treatment method, including: performing a skin treatment procedure on the skin of a patient, wherein the skin treatment procedure includes one of a chemical peel procedure, a dermabrasion...
US20170042943 LIQUID AMNION TRANSPLANT PRODUCT  
A transplant product made from human amniotic fluid has a supernatant from filtered and centrifuged amniotic fluid, the amniotic fluid when recovered aseptically having a clear, translucent to...
US20160256500 METHODS OF TREATING CHRONIC WOUNDS WITH AMNIOTIC FLUID HAVING ELEVATED LEVELS OF TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES  
Methods for treating chronic wounds with an amniotic fluid having a therapeutically effective amount of tissue inhibitors of matrix metalloproteinases (TIMPs) are described. The amniotic fluid can...
US20150290245 AGENT, PRODUCT AND USE  
The present invention relates to a composition for modulating tumor cell dissemination, in particular metastatic cancer cells. In particular, the invention relates to an agent for modulating...

Matches 1 - 18 out of 18